Moonlake Immunotherapeutics · NASDAQ:MLTX

Reich Kristian sold 1,100 Moonlake Immunotherapeutics shares (Form 4)

Traded Jul 27, 2026 · Filed Jul 29, 2026

On Jul 27, 2026, Reich Kristian (Chief Scientific Officer) sold 1,100 Moonlake Immunotherapeutics shares at US$20.00 for US$22,000 under a trading plan, leaving 2,711,198 shares. Filed Jul 29, 2026 (Form 4).

Sold
1,100 shares
Price
US$20.00
Value
US$22,000
Holding after
2,711,198 shares (held indirectly)
Trading plan
Yes (Made under a plan set in advance)
Role
Chief Scientific Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jul 27, 2026Class A ordinary shares, par value $0.0001 per shareSale1,100US$20.002,711,198Indirect

Source

View original at SEC

Related